Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Type
Date
News Topics
- (-) Isotopes (1)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (4)
- Climate Change (1)
- Composites (1)
- Computer Science (7)
- Coronavirus (3)
- Decarbonization (1)
- Energy Storage (4)
- Environment (1)
- Materials (10)
- Materials Science (15)
- Microscopy (4)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (5)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (1)
- Simulation (1)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (5)
- Transportation (5)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.